Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in May
7 Annual Truist Securities Life Sciences Summit, May 4 - 5, 2021
Members of uniQure s management team will participate in virtual one-on-one investor meetings throughout the day on Tuesday, May 4.
American Society of Gene and Cell Therapy (ASGCT) Virtual 2021, May 11 - 14, 2021
uniQure will have a significant presence at ASGCT with five data presentations, of which two are oral presentations including:
Clinical Outcomes in Patients With and Without Pre-existing Neutralizing Antibodies to the Vector: 6-Month Data from the Phase 3 HOPE-B Gene Therapy Trial of Etranacogene Dezaparvovec on Wednesday, May 12, 6:15 - 6:30 p.m. ET.
Share this article
Share this article
PITTSBURGH, April 30, 2021 /PRNewswire/ Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021. Chief Executive Officer Michael Goettler and Chief Financial Officer Sanjeev Narula will answer questions about the company at 9:10 a.m. ET.
Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
Hookipa Pharma IncApril 29, 2021 GMT
NEW YORK and VIENNA, Austria, April 29, 2021 (GLOBE NEWSWIRE) HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate and present at the following upcoming virtual investor conferences:
7th Annual Truist Securities Life Sciences Summit, May 4 – 5, 2021 Fireside Chat: May 4, 1:50pm ET
Bank of America 2021 Health Care Conference, May 10 – 13, 2021 Presentation: May 13, 1:15pm ET
Seelos Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
News provided by
Share this article
Share this article
NEW YORK, April 19, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 RBC Capital Markets Global Healthcare Conference, May 18-20, 2021.
Raj Mehra, Ph.D., Chairman and CEO, will present on Tuesday, May 18
th at 4:50pm ET and host 1x1 meetings on May 18
th and 19
th.
About Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company s robust portfolio includes several late-stage clinical asset